COVID-19 Vaccine Toolkit
The COVID-19 public health emergency (PHE) ended at the end of the day on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.
This toolkit is for health care providers. Review this page for information about the Medicare COVID-19 Vaccines Toolkit during and after the PHE.
This COVID-19 Vaccine Toolkit is for health care providers and includes information to describe:
- The COVID-19 vaccine Medicare coding structure
- Medicare payment rates for administering COVID-19 vaccines, including a timeline of FDA approvals and EUA amendments for COVID-19 vaccines
- How to bill correctly for administering vaccines, including roster and centralized billing
- Monoclonal antibody infusion for treating COVID-19
If you have questions about billing or reimbursement of vaccine administration for patients covered by private insurance or Medicaid, contact the respective health plan or state Medicaid agency.
|Patients who are moderately or severely immunocompromised (have a weakened immune system) are at increased risk of severe COVID-19 illness and death. And, the immune response following COVID-19 vaccination may differ for these patients. Learn about COVID-19 vaccine guidance for moderately or severely immunocompromised patients.